
    
      PicatoÂ® (ingenol mebutate) gel is the first and only ingenol mebutate product approved by the
      Food and Drug Administration (FDA) in 2012 for the topical treatment of AKs on the face and
      scalp (0.015% formulation) and on the trunk and extremities (0.05% formulation). The FDA
      approved regimen for ingenol mebutate gel, 0.015% for the treatment of AKs on the face and
      scalp is once-daily application of one unit dose tube for three consecutive days applied to
      one contiguous skin area of approximately 25 cm2 (e.g., 5 cm x 5 cm).
    
  